Organovo Holdings Company

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Founded Date: 2007
Last Funding Type: Series E
Headquarters: San Diego, California, United States
Investors Number: 2
Technology: Others
Employee Number: 51-100
Industry: PharmTech
Estimated Revenue: $1M to $10M
Funding Status: IPO
Total Funding: $117.4M